OSL
ONCOSIL MEDICAL LTDOncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company's lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
OSL
OSL
ONCOSIL MEDICAL LTD
OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company's lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy.
Fundamentals
Historical Data48 days
| Date | Short % | Gross Short |
|---|---|---|
| 14 Sept | — | — |
| 11 Sept | — | — |
| 10 Sept | — | — |
| 9 Sept | 0.00% | — |
| 8 Sept | 0.00% | — |
| 7 Sept | 0.00% | — |
| 4 Sept | 0.00% | — |
| 3 Sept | 0.00% | — |
| 2 Sept | 0.00% | — |
| 1 Sept | 0.00% | — |
| 31 Aug | 0.00% | — |
| 28 Aug | 0.00% | — |
Oncosil Medical LTD (OSL) Short Interest Summary
Oncosil Medical LTD (OSL) currently has 0.00% of its shares sold short (0 thousand shares, worth approximately $0K), based on ASIC short position data reported on 9 September 2026 (T+4 reporting lag). That makes OSL the #697 most shorted stock on the ASX most shorted list. Short interest in OSL is up 0.00% over the past week and down 0.00% over the past month. OSL is part of the Health Care sector on the ASX.
Recent OSL Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 9 Sept 2026 | 0.00% | 0.0M | $1.06 |
| 8 Sept 2026 | 0.00% | 0.0M | $1.07 |
| 7 Sept 2026 | 0.00% | 0.0M | $0.91 |
| 4 Sept 2026 | 0.00% | 0.0M | $1.04 |
| 3 Sept 2026 | 0.00% | 0.0M | $1.05 |
| 2 Sept 2026 | 0.00% | 0.0M | $1.08 |
| 1 Sept 2026 | 0.00% | 0.0M | $1.13 |
| 31 Aug 2026 | 0.00% | 0.0M | $1.15 |
| 28 Aug 2026 | 0.00% | 0.0M | $1.17 |
| 27 Aug 2026 | 0.00% | 0.0M | $1.15 |
OSL Short Selling — Frequently Asked Questions
What is Oncosil Medical LTD (OSL)'s current short interest?
Oncosil Medical LTD (OSL) currently has a short interest of 0.00% of total shares outstanding. This means 0.00% of OSL's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is OSL heavily shorted on the ASX?
OSL has a relatively low short interest of 0.00%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for OSL investors?
Short interest in OSL shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.00%, OSL's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this OSL short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for OSL.